We have established that progranulin plays a critical role in prostate [14–17] and bladder cancer by promoting tumor cell motility and invasion [18–21], in vivo tumor growth and sensitizing cancer cells to cisplatin treatment [22]. The gene discussed is GRN; the disease is urinary bladder cancer.